obesity-995x60.png
FEATURED ARTICLES
The Real Cost Of Sites Working Without An Enforceable Agreement: Why Your Site's Quality Of Earnings Is Suspect
Starting site work before an enforceable agreement may look like flexibility, but it can drain leverage, create unrecoverable costs, and raise financial reporting and GCP concerns.
-
![Lab Experiment-GettyImages-157697835]( "The U.S. Clinical Trial Recruiting Pipeline Report – August 2026")
The U.S. Clinical Trial Recruiting Pipeline Report – August 2026This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from July and August.
-
![elderly care, rehabilitation, recovery-GettyImages-2274991410]( "How VNS-REHAB Aims To Improve Stroke Recovery After Patients Have Plateaued")
How VNS-REHAB Aims To Improve Stroke Recovery After Patients Have PlateauedLearn how a stroke trial standardized intensive therapy, sustained patient adherence, and exposed access barriers after FDA approval.
-
![cancer cell screening, disease treatment medical-GettyImages-2176920684]( "Resensitizing Treatment-Resistant Cancer Holds Promise Over Replacing Once-Efficacious Therapies")
Resensitizing Treatment-Resistant Cancer Holds Promise Over Replacing Once-Efficacious TherapiesJohn Yu, MD, of Kairos Pharma, explains why reversing treatment resistance could extend the life of proven cancer therapies and improve patient outcomes.
SERVICES AND PRODUCTS
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.
YpsoDose supports a broad range of formulation and injection requirements. Its intuitive design ensures reliable, comfortable injections across conditions and environments.
Mobile ophthalmic clinical research and clinical trial on-site support services designed to address challenges across all trial phases and ensure reliable protection of ocular endpoints.